Barbara Ann Karmanos Cancer Institute

01/30/2026 | Press release | Archived content

IN THE NEWS – Steroids for Systemic Mastocytosis: What to Know

January 30, 2026

Patient Power

Suresh Balasubramanian, M.D., hematologist and medical oncologist, and member of the Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, disclosed some risks and side effects of taking steroids as part of the treatment plan for systemic mastocytosis, additional therapies that can be used instead or complement the steroid treatment, and when patients should let their physician know they may be experiencing side effects.

Read the article here.

Barbara Ann Karmanos Cancer Institute published this content on January 30, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 15, 2026 at 13:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]